Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Genetic Technologies Ltd

GTG.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Healthcare Facilities & Services ·

Australia Micro Cap Analyst: N/A

Last Close

$0.03

Market Cap $37.05M · Vol 10.07K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$37.05M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

N/A

vs Market

52W High

N/A

0.00% below

52W Low

N/A

0.00% above

Volume

10.07K

Avg 0

P/B

5.67

Price-to-book

ROE

N/A

Return on equity

Free Float

10.44%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Genetic Technologies Ltd (GTG.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GTG.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

N/A

YTD

N/A

-79.86%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$5.11M
Net Income	$-8,011,854.00
Revenue Growth (YoY)	-100.00%
Gross Margin	43.96%
Operating Margin	-164.41%
Net Profit Margin	-156.78%
ROE	N/A
ROA · ROIC	-114.22% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.35
P/B	5.67
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.34B

Technical Indicators

50-Day SMA	$0.03
200-Day SMA	$0.03
RSI (14)	50.00
Beta	N/A
52-Week High	N/A
52-Week Low	N/A

Volume Today	10.07K
Avg Daily Volume (30D)	0
Relative Volume	N/Ax
Volatility (10D)	0.00
Volatility (30D)	0.00
Free Float	10.44%

Analyst Consensus

N/A

Current Price $0.03

Mean Target N/A

52W LowN/A 52W HighN/A

Current

Target

N/A N/A

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SK4X23

ISINAU000000GTG7

CountryAustralia

Sub-IndustryHealthcare Facilities & Services (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

FRE.DE Fresenius SE & Co KGaA -1.22% DGX Quest Diagnostics Inc -0.69% 4013.SE Dr Sulaiman Al Habib Medical Services Group Company SJSC -1.64% MAXHEALTH.NS Max Healthcare Institute Ltd -0.46% UHS Universal Health Services Inc -0.70%

Company Profile

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. It offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType/Corporate: relates to geneType branded test sales and expense, includes corporate charges.